Nonsurgical Approach to Isolated Pancreatic Metastatic Malignant Melanoma: A Case Report and Review of the Literature

Isolated pancreatic metastases from melanoma are rare with high mortality rate and account for less than 1% of metastatic melanomas. Treatment options are limited with highest overall survival reported in those with complete surgical resection. Of cases reported in the literature with nonsurgical ma...

Full description

Saved in:
Bibliographic Details
Published in:JIM - high impact case reports 2022, Vol.10, p.23247096221111763-23247096221111763
Main Authors: Trad, George, Sheikhan, Nazanin, Nguyen, Andrew, Hader, Ismail
Format: Article
Language:English
Subjects:
Case Report
Case reports
Humans
Immunotherapy
Interferons - therapeutic use
Melanoma
Melanoma - pathology
Melanoma - therapy
Melanoma, Cutaneous Malignant
Metastasis
Pancreas
Pancreatic Neoplasms - secondary
Pancreatic Neoplasms - therapy
Skin Neoplasms - pathology
Skin Neoplasms - therapy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c484t-eabf6fdfbf45202eea8bc975f956c02e81571e4bd33b7e7349d3372553bf900b3
container_end_page 23247096221111763
container_issue
container_start_page 23247096221111763
container_title JIM - high impact case reports
container_volume 10
creator Trad, George
Sheikhan, Nazanin
Nguyen, Andrew
Hader, Ismail
description Isolated pancreatic metastases from melanoma are rare with high mortality rate and account for less than 1% of metastatic melanomas. Treatment options are limited with highest overall survival reported in those with complete surgical resection. Of cases reported in the literature with nonsurgical management, highest length of survival was reported to be 10 months. We report a case of malignant melanoma with isolated pancreatic metastasis treated with interferon therapy and immunotherapy, with evidence of progressive tumor shrinkage and survival at 38 months.
doi_str_mv 10.1177/23247096221111763
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_82dea13eb8d64df097c1da6ff915b803</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_23247096221111763</sage_id><doaj_id>oai_doaj_org_article_82dea13eb8d64df097c1da6ff915b803</doaj_id><sourcerecordid>2691459883</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-eabf6fdfbf45202eea8bc975f956c02e81571e4bd33b7e7349d3372553bf900b3</originalsourceid><addsrcrecordid>eNp1Uk1v1DAQjRCIVqU_gAuyxIXLFtuJY5sD0mrVwkrLhxCcrYkzzmaVjRfbKeLf10tKaUHMxc_Pb954RlMUzxm9YEzK17zklaS65pzlkHX5qDg9cosj-fgePinOY9zRHEpwJvXT4qQUqlJUytNi-ujHOIWutzCQ5eEQPNgtSZ6sox8gYUs-w2gDQuot-YAJYpohDH03wpgyOcDo9_CGLMkKIpIvePAhERjbDK97_EG8I2mLZNMnDJCmgM-KJw6GiOe351nx7ery6-r9YvPp3Xq13Cxspaq0QGhc7VrXuEpwyhFBNVZL4bSobb4rJiTDqmnLspEoy0pnJLkQZeM0pU15Vqxn39bDzhxCv4fw03jozS_Ch85AyO0MaBRvEViJjWrrqnVUS8taqJ3TTDSKltnr7ex1mJo9thbHFGB4YPrwZey3pvPXRnNNGeXZ4NWtQfDfJ4zJ7PtoccjjQz9Fw2vNKqGVOtZ6-Zd056cw5lEZLoUSlVa1zCo2q2zwMQZ0d59h1Bx3xPyzIznnxf0u7jJ-b0QWXMyCCB3-Kft_xxsPA8TH</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2758549867</pqid></control><display><type>article</type><title>Nonsurgical Approach to Isolated Pancreatic Metastatic Malignant Melanoma: A Case Report and Review of the Literature</title><source>PubMed (Medline)</source><source>SAGE Open Access Journals</source><source>Publicly Available Content (ProQuest)</source><creator>Trad, George ; Sheikhan, Nazanin ; Nguyen, Andrew ; Hader, Ismail</creator><creatorcontrib>Trad, George ; Sheikhan, Nazanin ; Nguyen, Andrew ; Hader, Ismail</creatorcontrib><description>Isolated pancreatic metastases from melanoma are rare with high mortality rate and account for less than 1% of metastatic melanomas. Treatment options are limited with highest overall survival reported in those with complete surgical resection. Of cases reported in the literature with nonsurgical management, highest length of survival was reported to be 10 months. We report a case of malignant melanoma with isolated pancreatic metastasis treated with interferon therapy and immunotherapy, with evidence of progressive tumor shrinkage and survival at 38 months.</description><identifier>ISSN: 2324-7096</identifier><identifier>EISSN: 2324-7096</identifier><identifier>DOI: 10.1177/23247096221111763</identifier><identifier>PMID: 35848077</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Case Report ; Case reports ; Humans ; Immunotherapy ; Interferons - therapeutic use ; Melanoma ; Melanoma - pathology ; Melanoma - therapy ; Melanoma, Cutaneous Malignant ; Metastasis ; Pancreas ; Pancreatic Neoplasms - secondary ; Pancreatic Neoplasms - therapy ; Skin Neoplasms - pathology ; Skin Neoplasms - therapy</subject><ispartof>JIM - high impact case reports, 2022, Vol.10, p.23247096221111763-23247096221111763</ispartof><rights>2022 American Federation for Medical Research</rights><rights>2022 American Federation for Medical Research. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 American Federation for Medical Research 2022 American Federation for Medical Research</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c484t-eabf6fdfbf45202eea8bc975f956c02e81571e4bd33b7e7349d3372553bf900b3</cites><orcidid>0000-0001-9702-4970</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290102/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2758549867?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,4009,21946,25732,27832,27902,27903,27904,36991,36992,44569,44924,45312,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35848077$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Trad, George</creatorcontrib><creatorcontrib>Sheikhan, Nazanin</creatorcontrib><creatorcontrib>Nguyen, Andrew</creatorcontrib><creatorcontrib>Hader, Ismail</creatorcontrib><title>Nonsurgical Approach to Isolated Pancreatic Metastatic Malignant Melanoma: A Case Report and Review of the Literature</title><title>JIM - high impact case reports</title><addtitle>J Investig Med High Impact Case Rep</addtitle><description>Isolated pancreatic metastases from melanoma are rare with high mortality rate and account for less than 1% of metastatic melanomas. Treatment options are limited with highest overall survival reported in those with complete surgical resection. Of cases reported in the literature with nonsurgical management, highest length of survival was reported to be 10 months. We report a case of malignant melanoma with isolated pancreatic metastasis treated with interferon therapy and immunotherapy, with evidence of progressive tumor shrinkage and survival at 38 months.</description><subject>Case Report</subject><subject>Case reports</subject><subject>Humans</subject><subject>Immunotherapy</subject><subject>Interferons - therapeutic use</subject><subject>Melanoma</subject><subject>Melanoma - pathology</subject><subject>Melanoma - therapy</subject><subject>Melanoma, Cutaneous Malignant</subject><subject>Metastasis</subject><subject>Pancreas</subject><subject>Pancreatic Neoplasms - secondary</subject><subject>Pancreatic Neoplasms - therapy</subject><subject>Skin Neoplasms - pathology</subject><subject>Skin Neoplasms - therapy</subject><issn>2324-7096</issn><issn>2324-7096</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1Uk1v1DAQjRCIVqU_gAuyxIXLFtuJY5sD0mrVwkrLhxCcrYkzzmaVjRfbKeLf10tKaUHMxc_Pb954RlMUzxm9YEzK17zklaS65pzlkHX5qDg9cosj-fgePinOY9zRHEpwJvXT4qQUqlJUytNi-ujHOIWutzCQ5eEQPNgtSZ6sox8gYUs-w2gDQuot-YAJYpohDH03wpgyOcDo9_CGLMkKIpIvePAhERjbDK97_EG8I2mLZNMnDJCmgM-KJw6GiOe351nx7ery6-r9YvPp3Xq13Cxspaq0QGhc7VrXuEpwyhFBNVZL4bSobb4rJiTDqmnLspEoy0pnJLkQZeM0pU15Vqxn39bDzhxCv4fw03jozS_Ch85AyO0MaBRvEViJjWrrqnVUS8taqJ3TTDSKltnr7ex1mJo9thbHFGB4YPrwZey3pvPXRnNNGeXZ4NWtQfDfJ4zJ7PtoccjjQz9Fw2vNKqGVOtZ6-Zd056cw5lEZLoUSlVa1zCo2q2zwMQZ0d59h1Bx3xPyzIznnxf0u7jJ-b0QWXMyCCB3-Kft_xxsPA8TH</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Trad, George</creator><creator>Sheikhan, Nazanin</creator><creator>Nguyen, Andrew</creator><creator>Hader, Ismail</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><general>SAGE Publishing</general><scope>AFRWT</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9702-4970</orcidid></search><sort><creationdate>2022</creationdate><title>Nonsurgical Approach to Isolated Pancreatic Metastatic Malignant Melanoma: A Case Report and Review of the Literature</title><author>Trad, George ; Sheikhan, Nazanin ; Nguyen, Andrew ; Hader, Ismail</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-eabf6fdfbf45202eea8bc975f956c02e81571e4bd33b7e7349d3372553bf900b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Case Report</topic><topic>Case reports</topic><topic>Humans</topic><topic>Immunotherapy</topic><topic>Interferons - therapeutic use</topic><topic>Melanoma</topic><topic>Melanoma - pathology</topic><topic>Melanoma - therapy</topic><topic>Melanoma, Cutaneous Malignant</topic><topic>Metastasis</topic><topic>Pancreas</topic><topic>Pancreatic Neoplasms - secondary</topic><topic>Pancreatic Neoplasms - therapy</topic><topic>Skin Neoplasms - pathology</topic><topic>Skin Neoplasms - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Trad, George</creatorcontrib><creatorcontrib>Sheikhan, Nazanin</creatorcontrib><creatorcontrib>Nguyen, Andrew</creatorcontrib><creatorcontrib>Hader, Ismail</creatorcontrib><collection>SAGE Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>JIM - high impact case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Trad, George</au><au>Sheikhan, Nazanin</au><au>Nguyen, Andrew</au><au>Hader, Ismail</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nonsurgical Approach to Isolated Pancreatic Metastatic Malignant Melanoma: A Case Report and Review of the Literature</atitle><jtitle>JIM - high impact case reports</jtitle><addtitle>J Investig Med High Impact Case Rep</addtitle><date>2022</date><risdate>2022</risdate><volume>10</volume><spage>23247096221111763</spage><epage>23247096221111763</epage><pages>23247096221111763-23247096221111763</pages><issn>2324-7096</issn><eissn>2324-7096</eissn><abstract>Isolated pancreatic metastases from melanoma are rare with high mortality rate and account for less than 1% of metastatic melanomas. Treatment options are limited with highest overall survival reported in those with complete surgical resection. Of cases reported in the literature with nonsurgical management, highest length of survival was reported to be 10 months. We report a case of malignant melanoma with isolated pancreatic metastasis treated with interferon therapy and immunotherapy, with evidence of progressive tumor shrinkage and survival at 38 months.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>35848077</pmid><doi>10.1177/23247096221111763</doi><orcidid>https://orcid.org/0000-0001-9702-4970</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2324-7096
ispartof JIM - high impact case reports, 2022, Vol.10, p.23247096221111763-23247096221111763
issn 2324-7096
2324-7096
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_82dea13eb8d64df097c1da6ff915b803
source PubMed (Medline); SAGE Open Access Journals; Publicly Available Content (ProQuest)
subjects Case Report
Case reports
Humans
Immunotherapy
Interferons - therapeutic use
Melanoma
Melanoma - pathology
Melanoma - therapy
Melanoma, Cutaneous Malignant
Metastasis
Pancreas
Pancreatic Neoplasms - secondary
Pancreatic Neoplasms - therapy
Skin Neoplasms - pathology
Skin Neoplasms - therapy
title Nonsurgical Approach to Isolated Pancreatic Metastatic Malignant Melanoma: A Case Report and Review of the Literature
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T01%3A20%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nonsurgical%20Approach%20to%20Isolated%20Pancreatic%20Metastatic%20Malignant%20Melanoma:%20A%20Case%20Report%20and%20Review%20of%20the%20Literature&rft.jtitle=JIM%20-%20high%20impact%20case%20reports&rft.au=Trad,%20George&rft.date=2022&rft.volume=10&rft.spage=23247096221111763&rft.epage=23247096221111763&rft.pages=23247096221111763-23247096221111763&rft.issn=2324-7096&rft.eissn=2324-7096&rft_id=info:doi/10.1177/23247096221111763&rft_dat=%3Cproquest_doaj_%3E2691459883%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c484t-eabf6fdfbf45202eea8bc975f956c02e81571e4bd33b7e7349d3372553bf900b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2758549867&rft_id=info:pmid/35848077&rft_sage_id=10.1177_23247096221111763&rfr_iscdi=true